Načítá se...
VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing
A significant number of fractures develop non‐union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non‐invasive alternative. The hypothesis was administration of VEGF and the CXCR4...
Uloženo v:
| Vydáno v: | J Orthop Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563072/ https://ncbi.nlm.nih.gov/pubmed/30345545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.24164 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|